Get the Stockscreener App
23.87
3.59%
-0.89
After Hours:
23.86
-0.01
-0.04%
Metsera Inc stock is traded at $23.87, with a volume of 459.98K.
It is down -3.59% in the last 24 hours and up +56.32% over the past month.
Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.
See More
Previous Close:
$24.76
Open:
$24.43
24h Volume:
459.98K
Relative Volume:
0.54
Market Cap:
$2.69B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.94%
1M Performance:
+56.32%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$23.19
$25.40
1-Week Range:
$21.10
$26.02
52-Week Range:
$12.30
$32.81
Metsera Inc Stock (MTSR) Company Profile
Name
Metsera Inc
Sector
Industry
Phone
(212) 784-6595
Address
3 WORLD TRADE CENTER, NEW YORK
Compare MTSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
23.87 | 2.69B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.99 | 128.84B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
527.78 | 65.38B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
549.65 | 39.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.15 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
231.99 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-25-25 | Initiated | BofA Securities | Buy |
| Feb-25-25 | Initiated | Evercore ISI | Outperform |
| Feb-25-25 | Initiated | Guggenheim | Buy |
Metsera Inc Stock (MTSR) Latest News
Metsera: A Must-Add To Your Watchlist Thanks To GLP-1 Obesity Promise (NASDAQ:MTSR) - Seeking Alpha
Metsera to Present at Bank of America 2025 Global Healthcare Conference - The Manila Times
Metsera Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Metsera Rings the Opening Bell - Nasdaq
Metsera Inc’s Market Journey: Closing Weak at 22.74, Down -5.17 - DWinneX
MTSR Shares Experience Surge in Value - knoxdaily.com
Nothing is Better Than Metsera Inc (MTSR) stock at the moment - Sete News
Viking among notable gainers as Pfizer raises deal prospects - MSN
Viking stock rises as Pfizer ups deal prospects (VKTX:NASDAQ) - Seeking Alpha
Metsera Inc. appoints new director and legal officer By Investing.com - Investing.com India
Metsera Inc. appoints new director and legal officer - Investing.com
A Guide To The Risks Of Investing In Metsera Inc (MTSR) - knoxdaily.com
Metric Analysis: Metsera Inc (MTSR)’s Key Ratios in the Limelight - DWinneX
A Closer Look at Metsera Inc (MTSR) Stock Gains - investchronicle.com
Metsera Inc (MTSR) stock analysis: A simple moving average approach - uspostnews.com
Metsera (NASDAQ:MTSR) Shares Gap Up – Time to Buy? - Defense World
Now Is The Time To Build A Position In Metsera Inc (NASDAQ:MTSR) - Marketing Sentinel
Metsera Inc [MTSR] Director makes an insider purchase of 2,222,222 shares worth 40.0 million. - knoxdaily.com
The Psychology of Metsera Inc Inc. (MTSR) Price Performance: Understanding Market Sentiment - investchronicle.com
Taking the lead: Metsera Inc (MTSR) - Sete News
Financial Metrics Exploration: Understanding Metsera Inc (MTSR) Through Ratios - DWinneX
How did Metsera Inc (MTSR) fare last session? - uspostnews.com
Lilly stock up rallying Structure and Metsera (GPCR:NASDAQ) - Seeking Alpha
Viking, Structure, Metsera on a tear as Pfizer drops obesity pill - MSN
Viking stock on a tear after Pfizer setback (VKTX:NASDAQ) - Seeking Alpha
Is it possible to buy Metsera Inc(MTSR) shares at a good price now? - uspostnews.com
Q1 IPOs Rise From Q4, But Unstable Markets Could Slow New Offerings - insights.citeline.com
Metsera plunges 44% after InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Exclusive: Metsera CEO on what it takes to build an obesity biotech in 2025 - Endpoints News
Metsera sees cash runway into 2027 - TipRanks
Metsera reports Q4 EPS ($3.52) vs. (94c) last year - TipRanks
Decoding Metsera Inc (MTSR): A Strategic SWOT Insight - GuruFocus
Are Metsera Inc’shares a good deal? - US Post News
Metsera's Q4 Net Loss Widens, Operating Expenses Rise; Shares Higher - marketscreener.com
Metsera Reports Fourth Quarter And Full Year 2024 Financial Results And Continued Portfolio Progress - Marketscreener.com
Form 10-K Metsera, Inc. For: Dec 31 - StreetInsider
Earnings Flash (MTSR) Metsera Posts Q4 Total Operating Expenses $64.5M - Marketscreener.com
Earnings Flash (MTSR) Metsera Posts Q4 Net Loss of $3.52 a Share - MarketScreener
Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress - The Manila Times
Metsera Inc (NASDAQ: MTSR) Stock Is Down -21.4% From Its Low: The Uptrend Is Still On - Stocks Register
Amneal Digs Deeper Into GLP-1 Aspirations Following Metsera’s IPO - insights.citeline.com
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On TuesdayDiginex (NASDAQ:DGNX), China Liberal Education (NASDAQ:CLEU) - Benzinga
Science Applications Posts Better-Than-Expected Earnings, Joins Qifu Technology, Baidu, American Eagle And Other Big Stocks Moving Higher On MondayAlpha Technology Group (NASDAQ:ATGL), American Eagle Outfitters (NYSE:AEO) - Benzinga
Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month - Insider Monkey
Top 10 Insider Purchases Last Month - Insider Monkey
Metsera, Inc. awards full bonuses to executive officers By Investing.com - Investing.com Australia
Metsera, Inc. awards full bonuses to executive officers - Investing.com India
Metsera, Inc. Approves 2024 Executive Cash Bonuses - TipRanks
Metsera Inc Stock (MTSR) Financials Data
There is no financial data for Metsera Inc (MTSR). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.84%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):